-
1
-
-
3042866655
-
-
Futuramed Verlag, München
-
Deutsche Gesellschaft für pädiatrische Infektiologie e.V. (ed): Handbuch 1995: Infektionen bei Kindern und Jugendlichen. Futuramed Verlag, München 1995, p. 443-448.
-
(1995)
Handbuch 1995: Infektionen bei Kindern und Jugendlichen
, pp. 443-448
-
-
-
2
-
-
10244227767
-
Group A streptococcal infections
-
Peter G (ed): American Academy of Pediatrics, Elk Grove Village, IL
-
American Academy of Pediatrics: Group A streptococcal infections. In: Peter G (ed): Red book: report of the Committee on Infectious Diseases. American Academy of Pediatrics, Elk Grove Village, IL, 1994, p. 434-436.
-
(1994)
Red Book: Report of the Committee on Infectious Diseases
, pp. 434-436
-
-
-
3
-
-
0025753089
-
A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal tonsillopharyngitis: A meta-analysis supporting the concept of microbial copathogenicity
-
Pichichero ME, Margolis PA: A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal tonsillopharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatric Infectious Disease Journal 1991, 10: 275-281.
-
(1991)
Pediatric Infectious Disease Journal
, vol.10
, pp. 275-281
-
-
Pichichero, M.E.1
Margolis, P.A.2
-
4
-
-
0027515582
-
Treatment of streptococcal pharyngotonsillitis: Reports of penicillin's demise are premature
-
Markowitz M, Gerber MA, Kaplan EL: Treatment of streptococcal pharyngotonsillitis: reports of penicillin's demise are premature. Journal of Pediatrics 1993, 123: 679-685.
-
(1993)
Journal of Pediatrics
, vol.123
, pp. 679-685
-
-
Markowitz, M.1
Gerber, M.A.2
Kaplan, E.L.3
-
6
-
-
0028232260
-
In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics
-
Coonan KM, Kaplan EL: In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics. Pediatric Infectious Disease Journal 1994, 13: 630-635.
-
(1994)
Pediatric Infectious Disease Journal
, vol.13
, pp. 630-635
-
-
Coonan, K.M.1
Kaplan, E.L.2
-
7
-
-
0028782894
-
Airway infections - How common is resistance to antibiotics
-
Ruckdeschel G: Airway infections - how common is resistance to antibiotics. Fortschritte der Medizin 1994, 112: 485-488.
-
(1994)
Fortschritte der Medizin
, vol.112
, pp. 485-488
-
-
Ruckdeschel, G.1
-
8
-
-
0026502178
-
Resistance to erythromycin in group A streptococci
-
Seppala H, Nissinen A, Jarvinen Hhuovinen S, Henriksson T, Herva E, Holm SE, Jahkola M, Katila ML, Klaukka T, Kontianinen S, Liimatainen O, Oinonen S, Passi-Metsomaa L, Huovinen P: Resistance to erythromycin in group A streptococci. New England Journal of Medicine 1992, 326: 292-297.
-
(1992)
New England Journal of Medicine
, vol.326
, pp. 292-297
-
-
Seppala, H.1
Nissinen, A.2
Jarvinen Hhuovinen, S.3
Henriksson, T.4
Herva, E.5
Holm, S.E.6
Jahkola, M.7
Katila, M.L.8
Klaukka, T.9
Kontianinen, S.10
Liimatainen, O.11
Oinonen, S.12
Passi-Metsomaa, L.13
Huovinen, P.14
-
9
-
-
0027957737
-
Reasons for failures in penicillin treatment of streptococcal tonsillitis and possible alternatives
-
Holm SE: Reasons for failures in penicillin treatment of streptococcal tonsillitis and possible alternatives. Pediatric Infectious Disease Journal 1994, 13, Supplement 1: 66-69.
-
(1994)
Pediatric Infectious Disease Journal
, vol.13
, Issue.1 SUPPL.
, pp. 66-69
-
-
Holm, S.E.1
-
10
-
-
84943984534
-
Penicillin V for group A streptococcal pharyngotonsillitis. A randomized trial of seven vs ten days' therapy
-
Schwartz RH, Wientzen RL, Pedreira F, Feroli EJ, Mella GW, Guandolo VL: Penicillin V for group A streptococcal pharyngotonsillitis. A randomized trial of seven vs ten days' therapy. Journal of the American Medical Association 1981, 246: 1790-1795.
-
(1981)
Journal of the American Medical Association
, vol.246
, pp. 1790-1795
-
-
Schwartz, R.H.1
Wientzen, R.L.2
Pedreira, F.3
Feroli, E.J.4
Mella, G.W.5
Guandolo, V.L.6
-
11
-
-
0023141466
-
Five vs ten days of penicillin V therapy for streptococcal tonsillopharyngitis
-
Gerber MA, Randolph MF, Chanatry J, Wright LL, De Meo K, Kaplan EL: Five vs ten days of penicillin V therapy for streptococcal tonsillopharyngitis. American Journal of Diseases of Children 1987, 141: 224-227.
-
(1987)
American Journal of Diseases of Children
, vol.141
, pp. 224-227
-
-
Gerber, M.A.1
Randolph, M.F.2
Chanatry, J.3
Wright, L.L.4
De Meo, K.5
Kaplan, E.L.6
-
12
-
-
0023911291
-
Five versus ten days treatment of group A streptococcal pharyngotonsillitis: A randomized controlled clinical trial with phenoxymethyl-penicillin and cefadroxil
-
Strömberg A, Schwan S, Cars O: Five versus ten days treatment of group A streptococcal pharyngotonsillitis: a randomized controlled clinical trial with phenoxymethyl-penicillin and cefadroxil. Scandinavian Journal of Infectious Diseases 1988, 20: 37-46.
-
(1988)
Scandinavian Journal of Infectious Diseases
, vol.20
, pp. 37-46
-
-
Strömberg, A.1
Schwan, S.2
Cars, O.3
-
13
-
-
10244267365
-
Obere Atemwegsinfektionen bei Kindern
-
Scholz H: Obere Atemwegsinfektionen bei Kindern. Chemotherapie Journal 1993, 2, Supplement 2: 45-47.
-
(1993)
Chemotherapie Journal
, vol.2
, Issue.2 SUPPL.
, pp. 45-47
-
-
Scholz, H.1
-
14
-
-
7344266936
-
Azithromycin suspension vs. penicillin suspension in treatment of children with streptococcal pharyngitis
-
Still JG: Azithromycin suspension vs. penicillin suspension in treatment of children with streptococcal pharyngitis. Clinical Pharmacology and Therapeutics 1993, 53: 195.
-
(1993)
Clinical Pharmacology and Therapeutics
, vol.53
, pp. 195
-
-
Still, J.G.1
-
15
-
-
0028824008
-
5-days cefixime therapy for bacterial pharyngitis and/or tonsillitis: Comparison with 10-day penicillin V therapy
-
Adam D, Cefixime Study Group, Hostalek U, Tröster K: 5-days cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. Infection 1995, 23, Supplement 2: 83-86.
-
(1995)
Infection
, vol.23
, Issue.2 SUPPL.
, pp. 83-86
-
-
Adam, D.1
Hostalek, U.2
Tröster, K.3
-
16
-
-
0028960309
-
Comparative efficacy and safety of four-day cefuroxime axetil and ten-day penicillin treatment of group A beta-hemolytic streptococcal tonsillopharyngitis in children
-
Aujard Y, Boucot I, Brahimi N, Chiche D, Bingen E: Comparative efficacy and safety of four-day cefuroxime axetil and ten-day penicillin treatment of group A beta-hemolytic streptococcal tonsillopharyngitis in children. Pediatric Infectious Disease Journal 1995, 14: 295-300.
-
(1995)
Pediatric Infectious Disease Journal
, vol.14
, pp. 295-300
-
-
Aujard, Y.1
Boucot, I.2
Brahimi, N.3
Chiche, D.4
Bingen, E.5
-
17
-
-
0026066844
-
Evaluation of cefadroxil, penicillin and erythromycin in the treatment of streptococcal tonsillopharyngitis
-
Milatovic D: Evaluation of cefadroxil, penicillin and erythromycin in the treatment of streptococcal tonsillopharyngitis. Pediatric Infectious Disease Journal 1991, 10, Supplement 10: 61-63.
-
(1991)
Pediatric Infectious Disease Journal
, vol.10
, Issue.10 SUPPL.
, pp. 61-63
-
-
Milatovic, D.1
-
18
-
-
0027960103
-
Effective short-course treatment of acute group A beta-hemolytic streptococcal tonsillopharyngitis
-
Pichichero ME, Gooch WM, Rodriguez W, Blumer JL, Aronoff SC, Jacobs RF, Musser JM: Effective short-course treatment of acute group A beta-hemolytic streptococcal tonsillopharyngitis. Archives of Pediatric and Adolescent Medicine 1994, 148: 1053-1060.
-
(1994)
Archives of Pediatric and Adolescent Medicine
, vol.148
, pp. 1053-1060
-
-
Pichichero, M.E.1
Gooch, W.M.2
Rodriguez, W.3
Blumer, J.L.4
Aronoff, S.C.5
Jacobs, R.F.6
Musser, J.M.7
-
19
-
-
0025663636
-
Five day treatment of pharyngotonsillitis with cefpodoxime proxetil
-
Portier H, Chavanet P, Gouyon JB, Guetat F: Five day treatment of pharyngotonsillitis with cefpodoxime proxetil. Journal of Antimicrobial Chemotherapy 1990, 26: 79-85.
-
(1990)
Journal of Antimicrobial Chemotherapy
, vol.26
, pp. 79-85
-
-
Portier, H.1
Chavanet, P.2
Gouyon, J.B.3
Guetat, F.4
-
20
-
-
0026658519
-
Guidelines for the diagnosis of rheumatic fever, 1992 update
-
Special Writing Group of the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association: Guidelines for the diagnosis of rheumatic fever, 1992 update. Journal of the American Medical Association 1992, 268: 2069-2073.
-
(1992)
Journal of the American Medical Association
, vol.268
, pp. 2069-2073
-
-
-
21
-
-
0023846067
-
Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States
-
Massell BF, Chute CG, Walker AM, Kurland GS: Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. New England Journal of Medicine 1988, 318: 280-286.
-
(1988)
New England Journal of Medicine
, vol.318
, pp. 280-286
-
-
Massell, B.F.1
Chute, C.G.2
Walker, A.M.3
Kurland, G.S.4
-
22
-
-
0028969884
-
Management of pediatric patients with group A beta-hemolytic streptococcus tonsillopharyngitis: Treatment opinions
-
Still JG: Management of pediatric patients with group A beta-hemolytic streptococcus tonsillopharyngitis: treatment opinions. Pediatric Infectious Disease Journal 1995, 14, Supplement: 57-61.
-
(1995)
Pediatric Infectious Disease Journal
, vol.14
, Issue.SUPPL.
, pp. 57-61
-
-
Still, J.G.1
-
23
-
-
0023853220
-
Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography
-
Croteau D, Begeron MG, LeBel M: Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography. Antimicrobial Agents and Chemotherapy 1988, 32: 561-565.
-
(1988)
Antimicrobial Agents and Chemotherapy
, vol.32
, pp. 561-565
-
-
Croteau, D.1
Begeron, M.G.2
LeBel, M.3
-
24
-
-
0028982091
-
Comparison of bioavailabilities of erythromycin estolate and erythromycin ethylsuccinate suspensions after oral multiple-dose administration
-
Potthast H, Schug B, Schwerdtle R, Blume H: Comparison of bioavailabilities of erythromycin estolate and erythromycin ethylsuccinate suspensions after oral multiple-dose administration. Pharmazie 1995, 50: 56-60.
-
(1995)
Pharmazie
, vol.50
, pp. 56-60
-
-
Potthast, H.1
Schug, B.2
Schwerdtle, R.3
Blume, H.4
-
25
-
-
0017057679
-
Concentrations of erythromycin in serum and tonsil: Comparison of the estolate and ethyl succinate suspensions
-
Ginsburg CM, McCracken GH, Culbertson MC: Concentrations of erythromycin in serum and tonsil: comparison of the estolate and ethyl succinate suspensions. Journal of Pediatrics 1976, 89: 1011-1013.
-
(1976)
Journal of Pediatrics
, vol.89
, pp. 1011-1013
-
-
Ginsburg, C.M.1
McCracken, G.H.2
Culbertson, M.C.3
-
27
-
-
0020286889
-
Management of group a streptococcal tonsillopharyngitis: A randomized controlled study of twice-daily erythromycin ethylsuccinate versus erythromycin estolate
-
Ginsburg CM, McCracken GH, Steinberg JB, Crow SD, Dildy BF, Lancaster K, Olsen K: Management of group A streptococcal tonsillopharyngitis: a randomized controlled study of twice-daily erythromycin ethylsuccinate versus erythromycin estolate. Pediatric Infectious Disease 1982, 1: 384-387.
-
(1982)
Pediatric Infectious Disease
, vol.1
, pp. 384-387
-
-
Ginsburg, C.M.1
McCracken, G.H.2
Steinberg, J.B.3
Crow, S.D.4
Dildy, B.F.5
Lancaster, K.6
Olsen, K.7
-
28
-
-
0020031850
-
Treatment of group A streptococcal tonsillopharyngitis in children
-
Ginsburg CM, McCracken GH, Steinberg JB, Crow SD, Dildy BF, Cope F, Zweighaft T: Treatment of group A streptococcal tonsillopharyngitis in children. Clinical Pediatrics 1982, 21: 83-88.
-
(1982)
Clinical Pediatrics
, vol.21
, pp. 83-88
-
-
Ginsburg, C.M.1
McCracken, G.H.2
Steinberg, J.B.3
Crow, S.D.4
Dildy, B.F.5
Cope, F.6
Zweighaft, T.7
-
29
-
-
0021268509
-
Erythromycin therapy for group A streptococcal tonsillopharyngitis
-
Ginsburg CM, McCracken GH, Crow SD, Dildy BR, Morchower G, Steinberg JB, Lancaster K: Erythromycin therapy for group A streptococcal tonsillopharyngitis. American Journal of Diseases of Children 1984, 138: 536-539.
-
(1984)
American Journal of Diseases of Children
, vol.138
, pp. 536-539
-
-
Ginsburg, C.M.1
McCracken, G.H.2
Crow, S.D.3
Dildy, B.R.4
Morchower, G.5
Steinberg, J.B.6
Lancaster, K.7
-
30
-
-
0019449504
-
The role of the carrier in treatment failures after antibiotic therapy for group A streptococci in the upper respiratory tract
-
Kaplan EL, Gastanaduy AS, Huwe BB: The role of the carrier in treatment failures after antibiotic therapy for group A streptococci in the upper respiratory tract. Journal of Laboratory and Clinical Medicine 1981, 98: 326-335.
-
(1981)
Journal of Laboratory and Clinical Medicine
, vol.98
, pp. 326-335
-
-
Kaplan, E.L.1
Gastanaduy, A.S.2
Huwe, B.B.3
-
31
-
-
0018952234
-
Failure of penicillin to eradicate group A streptococci during an outbreak of tonsillopharyngitis
-
Gastanaduy AS, Kaplan EL, Huwe BB, McKay C, Wannamaker LW: Failure of penicillin to eradicate group A streptococci during an outbreak of tonsillopharyngitis. Lancet 1980, ii: 498-502.
-
(1980)
Lancet
, vol.2
, pp. 498-502
-
-
Gastanaduy, A.S.1
Kaplan, E.L.2
Huwe, B.B.3
McKay, C.4
Wannamaker, L.W.5
-
32
-
-
0028087313
-
Streptococcal tonsillopharyngitis: The case for penicillin therapy
-
Shulman ST, Gerber MA, Tanz RR, Markowitz M: Streptococcal tonsillopharyngitis: the case for penicillin therapy. Pediatric Infectious Disease Journal 1994, 13: 1-7.
-
(1994)
Pediatric Infectious Disease Journal
, vol.13
, pp. 1-7
-
-
Shulman, S.T.1
Gerber, M.A.2
Tanz, R.R.3
Markowitz, M.4
|